Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence

Abstract

Purpose. This study aimed to evaluate reports of patents for oral care formulations, based on Camellia sinensis (C. sinensis), deposited and granted in intellectual property banks. Methods. A survey was conducted through collection, treatment, and analysis of extracted information from patent reports selected. The documentary research was conducted in January 2021 on formulations with C. sinensis for dental applications, including since the first patent deposits until the current time. The risk of bias of clinical trials with these formulations was analyzed to verify the scientific evidence. The data extracted represent the distribution of the number of patents by banks, annual evolution of patent deposits, applicant of patents by country, distribution of patents according to International Patent Classification codes, and the types of patented products. Results. Data and information from 20 selected patents were extracted. The United States Patent and Trademark Office (USPTO) and World Intellectual Property Organization (WIPO) were the banks with the largest number of patents for products/formulations with C. sinensis for oral care applications with 7 (35%) and 6 (30%) patent registrations, respectively. Other banks did not provide patents related to the search. Patents of compositions were the largest with 14 filings, and the remainder of formulations are represented specially by mouthwashes and toothpastes. As for clinical application, 18 patents were filed as products with antimicrobial and antibiofilm action, while 2 patents are directed to the treatment of xerostomia. In general, the aspects of the studies of clinical efficacy pointed to a low risk of bias. Conclusion. The study pointed out a small number of products protected by patents for Camellia sinensis for oral care indication, highlighting mainly mouthwash compositions and formulations. In the methodological parameters of clinical trials carried out with the formulations, the majority pointed out a low risk of bias.

Bioactive-Based Cosmeceuticals: An Update on Emerging Trends

“…Its chemical constituents include diterpene lactones and flavonoids, kaempferol, quercetin, etc. [ 59 ]. It is used as an antioxidant that smoothens, rejuvenates, and promotes a youthful appearance [ 59 ].…”

“…[ 59 ]. It is used as an antioxidant that smoothens, rejuvenates, and promotes a youthful appearance [ 59 ].…”

Evaluation of Chewing Gums Containing Natural Products on Salivary Concentrations of Streptococcus mutans in Children

“…Socio-economic, biological, behavioral, dietary factors and access to health services are decisive for its prevalence. [1][2][3][4] The national oral health policy lists conditions such as dental caries, periodontal disease and oral cancer as risks for systemic diseases that can affect the population. 5 Poor oral health conditions of the population, often associated with unfavorable socio-economic conditions, difficulty in accessing services and harmful habits, such as high consumption of sugar.…”

Fluoride concentration in teas derived from Camellia Sinensis produced in Argentina

“…The F − concentrations have shown to vary according its georeference and has unquestionable evidence regarding its effects in preventing and controlling dental caries lesions (Hayacibara et al, 2004;Malinowska et al, 2008;Opydo-Szymaczek et al, 2010;Salahinejad & Aflaki, 2010;Lv et al, 2013;Linhares et al, 2017). On these lines, and because of other putative antimicrobial tea properties, C. sinensis has been added to dental formulations (Valadas et al, 2021).…”